198
Views
10
CrossRef citations to date
0
Altmetric
Article

ORAL LORAZEPAM PREVENTS SEIZURE DURING HIGH-DOSE BUSULFAN IN CHILDREN UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION: A Prospective Study

, , , , &
Pages 529-533 | Accepted 23 May 2010, Published online: 02 Aug 2010

REFERENCES

  • Tutschka PJ, Santon GW. Bone marrow transplantation in the busulfan-treated rat, III: relationship between myelosuppression and immunosuppression for conditioning bone marrow recipients. Transplantation. 1977;24:52–62.
  • Santos GW, Tutschka PJ, Brookmeyer R, Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide. N Engl J Med. 1983;309:1347–1353.
  • Vassal, G, Gouyette A, Hartmann O, Pharmacokinetics of high-dose busulfan in children. Cancer Chemother. Pharmacol. 1989;24:386–390.
  • Santos GW. Busulfan (Bu) and cyclophosphamide (Cy) for marrow transplantation. Bone Marrow Transplant. 1989;4(Suppl 1):236–139.
  • Vassal G, Deroussent A, Hartmann O, Dose-dependent neurotoxicity of high-dose busulfan in children: a clinical and pharmacological study. Cancer Res. 1990;50:6203–6207.
  • Hassan M, Oberg G, Bjorkholm M, Influence of prophylactic anticonvulsant therapy on high-dose busulfan kinetics. Cancer Chemother Pharmacol. 1993;33:181–186.
  • Chan KW, Mullen CA, Worth LL, Lorazepam for seizure prophylaxis during high-dose busulfan administration. Bone Marrow Transplant. 2002;29:963–965.
  • Hobbs JR, Hugh-Jones K, Shaw PJ, Engraftment rates related to busulfan and cyclophosphamide dosages for displacement bone marrow transplants in fifty children. Bone Marrow Transplant. 1986;1:201–208.
  • Lin KH, Lin KS, Freig SA. Marrow transplantation for thalassemia. Bone Marrow Transplant. 1986;1:115–120.
  • Bishop JB, Wassom JS. Toxicological review of busulfan (Myleran). Mutat Res. 1986;168:15–45.
  • Marcus RE, Goldman JM. Convulsions due to high-dose busulfan. Lancet. 1984;2:1463.
  • Neef C, De Voogd-van der Straaten I. An interaction between cytostatic and anticonvulsant drugs. Clin Pharmacol Ther. 1988;43:372–375.
  • Shaw PJ, Scharping CE, Brian RJ, Busulfan pharmacokinetics using a single daily high-dose regimen in children with acute leukemia. Blood. 1994;84:2357–2362.
  • Meloni G, Nasta L, Pinto RM, Clonazepam prophylaxis and busulfan-related myoclonic epilepsy in autografted acute leukemia patients. Haematologica. 1995;80:532–534.
  • Caselli D, Ziino O, Bartoli A, Continuous intravenous infusion of lorazepam as seizure prophylaxis in children treated with high-dose busulfan. Bone Marrow Transplant. 2008;42:135–136.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.